Results for tag: "Eprozinol"

Eprozinol is a respiratory drug used to treat asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. It is a long-acting beta-agonist (LABA) that works by relaxing the muscles of the airways, allowing more air to flow in and out of the lungs. It is usually taken twice daily, either as an inhaler or a tablet. Eprozinol is often used in combination with other medications, such as corticosteroids, to provide better control of symptoms. Eprozinol is a widely used drug in the respiratory market, with many generic and branded versions available. It is often prescribed as a first-line treatment for asthma and COPD, and is also used to treat other respiratory conditions such as bronchitis and emphysema. It is generally well-tolerated, with few side effects. Companies in the Eprozinol market include GlaxoSmithKline, Merck, AstraZeneca, Boehringer Ingelheim, and Novartis. Show Less Read more